NVIDIA & Lilly Forge AI-Driven Drug Discovery Blueprint
Analysis
Key Takeaways
- •NVIDIA and Lilly are collaborating on an AI-driven drug discovery initiative.
- •The collaboration aims to create a 'blueprint' for future advancements.
- •The announcement was made at the J.P. Morgan Healthcare Conference.
“NVIDIA founder and CEO Jensen Huang told attendees… ‘a blueprint for what is possible in the future of drug discovery’”